Navitoclax (ABT-263) –BCL-2 Inhibitor for Bulk Orders

Mitora™ Navitoclax (ABT-263) is a high-purity BCL-2 inhibitor and research-grade senolytic compound widely used in cellular senescence, oncology, and apoptosis research. Navitoclax selectively targets anti-apoptotic BCL-2 family proteins, making it a powerful tool for senescent cell clearance and preclinical studies. Designed for B2B distribution, academic laboratories, and biotech research, it ensures consistent quality and reproducibility. 

• High Purity: ≥99% purity ensures reliable and reproducible experimental results.
   
• Research-Grade Quality: Ideal for in vitro studies, apoptosis assays, and preclinical research.
   
• Bulk Supply Availability: Flexible quantities to meet B2B distributor, laboratory, and institutional research needs.
   
• Certificate of Analysis (COA): Each batch includes a COA verifying purity, identity, and quality.
   
• Senolytic Applications: Widely used in senescent cell clearance studies and BCL-2 pathway investigations.

• Chemical Name: Navitoclax (ABT-263)
   
• CAS Number: 923564-51-6
   
• Appearance: Off-white to pale-yellow crystalline powder
   
• Purity: ≥99%
   
• Storage: Store in a cool, dry place, protected from light

As a trusted senolytic compound supplier, Mitora™ provides Navitoclax (ABT-263) in bulk to global research and B2B clients. Our strict quality control, reliable sourcing, and international shipping ensure that researchers and distributors have consistent, high-quality compounds for their studies.

• Preferred by academic institutions, biotech firms, and global B2B distributors.
   
• Compliant with research use only (RUO) regulations.
   
• Securely packaged for safe international transport.